MED01-P2 — ChatGPT correction round 1 — RAW, verbatim
Received 2026-10-06 via Danny’s paste; reply to ../../correction-prompts-P2.md (ChatGPT, 3 items), given in ChatGPT’s P2 chat. Filed beside the frozen Stage 1 and Stage 2 passes, which are unchanged. Verifier re-resolution (base Rule 9) below the raw text.
- ISRCTN record opened: registered title “Pilot study of smoked cannabis for chronic neuropathic pain”; registration date 21/06/2006; registered primary outcome: “Average pain intensity measured daily during each cycle by 100 mm visual analogue scale (VAS),” averaged across study days per cycle as the main outcome · ISRCTN68314063 · verified live. ISRCTN
- Experimentally induced pain was a secondary outcome. Registered primary outcome: “Change in level of HIV-related neuropathic pain as recorded on a 100mm Visual Analog Scale.” · NCT00046722 · verified live. ClinicalTrials.gov
- CAND-03 correction: The estimated difference in mean reduction in total Ashworth score was 0.32 (95% CI −1.04 to 1.67) for cannabis extract compared with placebo, and 0.94 (−0.44 to 2.31) for Δ9-THC versus placebo; overall p=0.40 · PMID 14615106; DOI 10.1016/S0140-6736(03)14738-1 · verified live. pubmed.ncbi.nlm.nih.gov
Verifier re-resolution (2026-10-06)
| # | Result | Check |
|---|---|---|
| 1 | Confirmed. ISRCTN API record: public title “Pilot study of smoked cannabis for chronic neuropathic pain”; scientific title “Smoked cannabis for chronic neuropathic pain: a randomised controlled trial”; ISRCTN assigned 2006-06-21; primary outcome begins “Average pain intensity measured daily during each cycle by 100 mm visual analogue scale (VAS)”. Verifier-found: recruitment start 2003-08-01, overall end 2006-01-31 — the trial was registered after its recorded end date (retrospective registration). The registry text also names an 11-point numerical rating scale; the publication’s primary contrast used the 11-point NRS. Record last updated 2010-11-10 (version 36). | ISRCTN XML API |
| 2 | Confirmed. Matches the ClinicalTrials.gov v2 record read in verification run 1. Abrams 2007’s registered primary (100-mm VAS neuropathic pain) matches the published primary. | ClinicalTrials.gov API v2 |
| 3 | Confirmed. Wording matches the PubMed abstract exactly (0.32, −1.04 to 1.67; 0.94, −0.44 to 2.31; p=0.40). | PubMed EFetch |
ChatGPT correction round 1: 3/3 resolved, 0 new failures.